HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
thionapthene-2-carboxylic acid-lysine
potent antihypercalcemic agent
Also Known As:
TNLY; thionapthene-2-carboxylic acid lysine salt
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Amino Acids, Peptides, and Proteins: 1
Amino Acids: 30675
Essential Amino Acids: 1152
Lysine: 6737
thionapthene-2-carboxylic acid-lysine: 1
Basic Amino Acids: 178
Lysine: 6737
thionapthene-2-carboxylic acid-lysine: 1
Diamino Amino Acids: 101
Lysine: 6737
thionapthene-2-carboxylic acid-lysine: 1
Organic Chemicals: 133
Sulfur Compounds: 278
Thiophenes: 257
thionapthene-2-carboxylic acid-lysine: 1
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Thiophenes: 257
thionapthene-2-carboxylic acid-lysine: 1
Related Diseases
1.
Neoplasms (Cancer)
01/01/1989 - "
The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.
"
01/01/1989 - "
In tumor-bearing rats that were not yet hypercalcemic, pretreatment with TNLY (0.9 mmol/kg/day) did not induce hypocalcemia and the onset of hypercalcemia was prevented.
"
2.
Leydig Cell Tumor
01/01/1989 - "
We have assessed thionapthene-2-carboxylic acid lysine salt (TNLY) for its effects on serum calcium concentration and survival in rats bearing the hypercalcemic Leydig cell tumor.
"
3.
Hypocalcemia
01/01/1989 - "
In tumor-bearing rats that were not yet hypercalcemic, pretreatment with TNLY (0.9 mmol/kg/day) did not induce hypocalcemia and the onset of hypercalcemia was prevented.
"
4.
Hypercalcemia (Milk Alkali Syndrome)
01/01/1989 - "
The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.
"
01/01/1989 - "
In tumor-bearing rats that were not yet hypercalcemic, pretreatment with TNLY (0.9 mmol/kg/day) did not induce hypocalcemia and the onset of hypercalcemia was prevented.
"
5.
Bone Resorption
01/01/1989 - "
Neither TNLY nor dichloromethylene diphosphonate (CL2MDP), a potent inhibitor of bone resorption, significantly prolonged overall survival.
"
Related Drugs and Biologics
1.
thionapthene-2-carboxylic acid-lysine
2.
Clodronic Acid (Clodronate)
3.
Calcium